Immunization programs are essential to address mortality and morbidity associated with vaccine-preventable diseases. A case in point is hepatitis B, which is associated with cirrhosis and liver cancer. To increase hepatitis B vaccinations, the Centers for Disease Control and Prevention has shifted from recommending vaccination based on risk factors to recommending universal vaccination of adults between the ages of 19 and 59.

In addition to discussing issues related to hepatitis B vaccination, this roundtable included discussion of several general vaccination topics. Those topics included the primary public health aspects of vaccination programs, metrics to gauge the effectiveness or vaccination programs, and provider-facing and patient-facing strategies for increasing immunization.

Read on to gain valuable insights from this virtual roundtable about hepatitis B vaccination and general vaccination topics.